デフォルト表紙
市場調査レポート
商品コード
1429333

自己免疫疾患診断の世界市場レポート 2024年

Autoimmune Disease Diagnosis Global Market Report 2024

出版日: 受注後更新 | 発行: The Business Research Company | ページ情報: 英文 175 Pages | 納期: 2~10営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報(例:国別セグメント)の追加などの対応が可能です。  詳細はお問い合わせください。

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=157.33円
自己免疫疾患診断の世界市場レポート 2024年
出版日: 受注後更新
発行: The Business Research Company
ページ情報: 英文 175 Pages
納期: 2~10営業日
  • 全表示
  • 概要
  • 目次
概要

自己免疫疾患診断の市場規模は、今後数年間で大幅な成長が見込まれています。 2028年には8.4%の年間複合成長率(CAGR)で83億6,000万米ドルに成長すると予想されます。予測期間中に予想される成長は、自己免疫(AI)診断への資金提供の増加、経済成長の加速、自己免疫疾患に対する意識の高まり、バイオマーカー発見の進歩など、いくつかの要因に起因すると考えられます。予測期間中に予想される主要な動向には、他の業界参入企業との戦略的パートナーシップ、人工知能(AI)企業への投資、政府機関との協力、家庭用迅速検査キットの開発などが含まれます。

自己免疫疾患の有病率の急増は、自己免疫疾患診断市場の拡大に大きく貢献しています。特に、2023年2月、オーストラリア多発性硬化症協会は、オーストラリアにおける多発性硬化症(MS)症例の大幅な増加を報告し、2021年の患者数は3万3,335人に達したと記録されました。この数字は、過去4回と比べて30%(7,728人)という顕著な急増を反映しています。前期の2万5,607人から増加しました。自己免疫疾患の発生率が世界的に増加していることが、自己免疫疾患診断市場で見られる需要の高まりと成長の原動力となっています。

自己免疫疾患診断市場の予想される成長は、近年観察される医療費の高騰と密接に絡み合っています。医療関連の製品やサービスに割り当てられた総リソースを定量化した医療支出は、国民の健康と医療システムの有効性を示す基本的な指標として機能します。医療支出の増加は医療サービスへの迅速なアクセスにつながり、その結果、自己免疫疾患に苦しむ個人の特定、治療、転帰の強化につながります。特に、2023年9月の時点で、米国のCenters for Medicare & Medicaid Servicesは、国民医療支出が2.7パーセント増加し、2021年には4兆3,000億米ドルという驚異的な額に達し、個人当たり平均1万2,914米ドルに達し、国内総生産の18.3%を占めると明らかにした( GDP)。この医療支出の上昇傾向は、依然として自己免疫疾患診断市場の進歩を推進する極めて重要な触媒となっています。

目次

第1章 エグゼクティブサマリー

第2章 市場の特徴

第3章 市場動向と戦略

第4章 マクロ経済シナリオ

  • 高インフレが市場に与える影響
  • ウクライナ・ロシア戦争が市場に与える影響
  • COVID-19による市場への影響

第5章 世界市場規模と成長

  • 世界の自己免疫疾患診断市場の促進要因と抑制要因
    • 市場促進要因
    • 市場抑制要因
  • 世界の自己免疫疾患診断の市場規模実績と成長、2018~2023年
  • 世界の自己免疫疾患診断市場規模と成長予測、2023~2028年、2033年

第6章 市場セグメンテーション

  • 世界の自己免疫疾患診断市場、製品別セグメンテーション、実績と予測、2018~2023年、2023~2028年、2033年
  • 消耗品とアッセイキット
  • 機器
  • 世界の自己免疫疾患診断市場、検査タイプ別セグメンテーション、実績と予測、2018~2023年、2023~2028年、2033年
  • 定期臨床検査
  • 自己抗体検査
  • 免疫学的検査
  • その他
  • 世界の自己免疫疾患診断市場、エンドユーザー別セグメンテーション、実績と予測、2018~2023年、2023~2028年、2033年
  • 臨床検査室
  • 病院
  • その他

第7章 地域と国の分析

  • 世界の自己免疫疾患診断市場、地域別、実績と予測、2018~2023年、2023~2028年、2033年
  • 世界の自己免疫疾患診断市場、国別、実績と予測、2018~2023年、2023~2028年、2033年

第8章 アジア太平洋市場

第9章 中国市場

第10章 インド市場

第11章 日本市場

第12章 オーストラリア市場

第13章 インドネシア市場

第14章 韓国市場

第15章 西欧市場

第16章 英国市場

第17章 ドイツ市場

第18章 フランス市場

第19章 イタリア市場

第20章 スペイン市場

第21章 東欧市場

第22章 ロシア市場

第23章 北米市場

第24章 米国市場

第25章 カナダ市場

第26章 南米市場

第27章 ブラジル市場

第28章 中東市場

第29章 アフリカ市場

第30章 競合情勢と企業プロファイル

  • 自己免疫疾患診断市場の競合情勢
  • 自己免疫疾患診断市場の企業プロファイル
    • Siemens Healthineers AG
    • Abbott Laboratories
    • Thermo Fisher Scientific Inc
    • Bio-Rad Laboratories Inc
    • F. Hoffmann-La Roche Ltd

第31章 その他の大手と革新的な企業

  • Danaher Corporation
  • AESKU Diagnostics GmbH &Co. KG
  • Trinity Biotech plc.
  • bioMerieux SA
  • SQI Diagnostics
  • SCHILLER Healthcare India Pvt. Ltd
  • Covidien Healthcare India Private Limited
  • Philips Healthcare India
  • Fisher &Paykel Healthcare India Private Limited
  • Smith's Medical India Pvt Ltd
  • Agappe Diagnostics Ltd
  • Accord Medical Products Private Limited
  • Terumo Corporation
  • Olympus Medical Systems Corporation
  • Canon Medical Systems Corporation

第32章 競合ベンチマーキング

第33章 競合ダッシュボード

第34章 主要な合併と買収

第35章 将来の展望と潜在性分析

第36章 付録

目次
Product Code: r14345

Autoimmune diseases are characterized by the body's production of antibodies that target and attack its own healthy cells, leading to their destruction. Conditions falling under this category include Crohn's disease, rheumatoid arthritis, Hashimoto's disease, multiple sclerosis, Grave's disease, psoriasis, coeliac disease, type 1 diabetes, lupus, and inflammatory bowel syndrome. The diagnosis of these diseases typically involves immunological tests.

The primary types of tests used for autoimmune disease diagnosis include routine laboratory tests, autoantibody tests, immunologic tests, and other specialized tests. Autoantibody tests play a crucial role in aiding the diagnosis of autoimmune diseases. Various products, such as consumables and assay kits, as well as instruments, are employed in these diagnostic processes. These diagnostic tools find application in diverse sectors, including clinical laboratories, hospitals, and other relevant healthcare settings.

The autoimmune disease diagnosis market research report is one of a series of new reports from The Business Research Company that provides autoimmune disease diagnosis market statistics, including autoimmune disease diagnosis industry global market size, regional shares, competitors with a autoimmune disease diagnosis market share, detailed autoimmune disease diagnosis market segments, market trends and opportunities, and any further data you may need to thrive in the autoimmune disease diagnosis industry. This autoimmune disease diagnosis market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The autoimmune disease diagnosis market size has grown strongly in recent years. It will grow from $5.56 billion in 2023 to $6.05 billion in 2024 at a compound annual growth rate (CAGR) of 8.7%. The growth observed during the historical period can be attributed to several factors, including the increasing incidence of autoimmune diseases, the expansion of emerging markets, higher healthcare expenditure, and a notable prevalence of these diseases in women.

The autoimmune disease diagnosis market size is expected to see strong growth in the next few years. It will grow to $8.36 billion in 2028 at a compound annual growth rate (CAGR) of 8.4%. The anticipated growth in the forecast period can be attributed to several factors, including increased funding for autoimmune (AI) diagnostics, accelerated economic growth, a heightened awareness regarding autoimmune diseases, and advancements in biomarker discovery. Key trends expected in the forecast period involve strategic partnerships with other industry players, investments in artificial intelligence (AI) companies, collaboration with government entities, and the development of at-home rapid test kits.

A surge in the prevalence of autoimmune diseases has significantly contributed to the expansion of the autoimmune disease diagnosis market. Notably, in February 2023, Multiple Sclerosis Australia reported a substantial increase in Multiple Sclerosis (MS) cases in Australia, with a recorded count of 33,335 patients in 2021. This figure reflects a notable surge of 30% (7,728 individuals) over the previous four years, from 25,607 in the preceding period. The escalating incidence of autoimmune disorders globally stands as a driving force behind the heightened demand and growth witnessed within the autoimmune disease diagnosis market.

The anticipated growth of the autoimmune disease diagnosis market is closely intertwined with the escalating healthcare expenditures observed in recent years. Healthcare expenditure, quantifying the total resources allocated to healthcare-related products and services, serves as a fundamental metric indicating population health and healthcare system efficacy. Heightened healthcare spending translates to expedited access to healthcare services, consequently leading to enhanced identification, treatment, and outcomes for individuals afflicted by autoimmune conditions. Notably, as of September 2023, the Centers for Medicare & Medicaid Services in the United States disclosed a 2.7 percent increase in national health spending, reaching a staggering $4.3 trillion in 2021, averaging $12,914 per individual and representing 18.3% of the Gross Domestic Product (GDP). This upward trajectory in healthcare expenditure remains a pivotal catalyst propelling advancements within the autoimmune disease diagnosis market.

Biosensors and nano biosensors stand as groundbreaking tools within the autoimmune disease diagnosis market, offering rapid and efficient antibody detection. These cutting-edge technologies are favored for their cost-effectiveness, exceptional sensitivity, user-friendly nature, multiplexing capabilities, and swift diagnostic outcomes. Beyond merely measuring antibody quantities in human blood serum with remarkable sensitivity, they also gauge antibody activity utilizing portable optical label-free biosensors grounded in spectral correlation interferometry. This point-of-care technology delivers a more integrated, informative, timely, and precise diagnosis of autoimmune diseases compared to traditional methods, enhancing the diagnostic landscape significantly.

Leading entities operating in the autoimmune disease diagnosis market are directing their efforts toward pioneering solutions such as the Phadia 2500+ series autoimmune testing instruments, aiming to better cater to the demands of their clientele. These antibody instruments are instrumental in conducting laboratory tests designed to identify autoimmune disorders. Particularly noteworthy, in May 2022, Thermo Fisher Scientific Inc., a prominent US-based company specializing in life sciences solutions, specialized diagnostics, laboratory services, and biotechnology, introduced the innovative Phadia 2500+ range of equipment. This advanced series of instruments offers expanded capabilities, facilitating integration and further automation for EliA autoimmune diagnostics. Its enhanced functionalities assist in diagnosing various autoimmune diseases, including but not limited to celiac disease, connective tissue disease (CTD), antiphospholipid syndrome (APS), rheumatoid arthritis, autoimmune thyroid disease, and autoimmune liver disease, catering to the diverse spectrum of autoimmune conditions.

Major companies operating in the autoimmune disease diagnosis market report are Siemens Healthineers AG, Abbott Laboratories, Thermo Fisher Scientific Inc., Bio-Rad Laboratories Inc., F. Hoffmann-La Roche Ltd., Danaher Corporation, AESKU Diagnostics GmbH & Co. KG, Trinity Biotech plc., bioMerieux SA, SQI Diagnostics, SCHILLER Healthcare India Pvt. Ltd., Covidien Healthcare India Private Limited, Philips Healthcare India, Fisher & Paykel Healthcare India Private Limited, Smith's Medical India Pvt Ltd., Agappe Diagnostics Ltd., Accord Medical Products Private Limited, Terumo Corporation, Olympus Medical Systems Corporation, Canon Medical Systems Corporation, Hitachi Group, Nihon Koden Corporation, Sanko Manufacturing Co.,Ltd., Fukuda Denshi, Metran Co., Ltd , Shinva Medical Instrument Company Limited, Shandong WeiGao Group Medical Polymer Company Limited, Lepu Medical Technology Company (Beijing) Co., Ltd., Yuwell - Jiangsu Yuyue Medical Equipment & Supply Co., Ltd., Shanghai Runda Medical Technology Co., Ltd., GE Healthcare China Co., Ltd., Roche Holding AG, Koninklijke Philips, Theradiag, Sanofi, Fresenius Medical Care, Novartis, Merck, Bayer, Medtronic, Draegerwerk AG, Getinge Group, Themis Bioscience, Stryker, Apotex, Bausch Health, Pfizer, HYCOR Biomedical, Exagen Inc., Kronus, Inova Diagnostics, Masimo, Teleflex Inc., 3M, Johnson & Johnson, Becton Dickinson, B. Braun Medical Inc., ResMed Inc

North America was the largest region in the autoimmune disease diagnosis market in 2023. Western Europe was the second largest region in the autoimmune disease diagnosis market share. The regions covered in the autoimmune disease diagnosis market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

The countries covered in the autoimmune disease diagnosis market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Italy, Canada, Spain

The autoimmune disease diagnosis market includes revenue earned by diagnostic assay kits, reagents, consumables, and instruments used for the diagnosis of autoimmune diseases. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Autoimmune Disease Diagnosis Global Market Report 2024 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on autoimmune disease diagnosis market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 50+ geographies.
  • Understand how the market has been affected by the coronavirus and how it is responding as the impact of the virus abates.
  • Assess the Russia - Ukraine war's impact on agriculture, energy and mineral commodity supply and its direct and indirect impact on the market.
  • Measure the impact of high global inflation on market growth.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on the latest market shares.
  • Benchmark performance against key competitors.
  • Suitable for supporting your internal and external presentations with reliable high quality data and analysis
  • Report will be updated with the latest data and delivered to you within 3-5 working days of order along with an Excel data sheet for easy data extraction and analysis.
  • All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for autoimmune disease diagnosis? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The autoimmune disease diagnosis market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

  • The market characteristics section of the report defines and explains the market.
  • The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
  • The forecasts are made after considering the major factors currently impacting the market. These include:

The impact of sanctions, supply chain disruptions, and altered demand for goods and services due to the Russian Ukraine war, impacting various macro-economic factors and parameters in the Eastern European region and its subsequent effect on global markets.

The impact of higher inflation in many countries and the resulting spike in interest rates.

The continued but declining impact of covid 19 on supply chains and consumption patterns.

  • Market segmentations break down the market into sub markets.
  • The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
  • The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
  • The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

Markets Covered:

  • 1) By Product: Consumables And Assay Kits; Instruments
  • 2) By End User: Clinical Laboratories; Hospitals; Others
  • 3) By Test Type: Routine Laboratory Tests; Autoantibodies Tests; Immunologic Tests; Other Tests
  • Companies Mentioned: Siemens Healthineers AG; Abbott Laboratories; Thermo Fisher Scientific Inc; Bio-Rad Laboratories Inc; F. Hoffmann-La Roche Ltd
  • Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
  • Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
  • Time series: Five years historic and ten years forecast.
  • Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
  • Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
  • Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
  • Delivery Format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Autoimmune Disease Diagnosis Market Characteristics

3. Autoimmune Disease Diagnosis Market Trends And Strategies

4. Autoimmune Disease Diagnosis Market - Macro Economic Scenario

  • 4.1. Impact Of High Inflation On The Market
  • 4.2. Ukraine-Russia War Impact On The Market
  • 4.3. COVID-19 Impact On The Market

5. Global Autoimmune Disease Diagnosis Market Size and Growth

  • 5.1. Global Autoimmune Disease Diagnosis Market Drivers and Restraints
    • 5.1.1. Drivers Of The Market
    • 5.1.2. Restraints Of The Market
  • 5.2. Global Autoimmune Disease Diagnosis Historic Market Size and Growth, 2018 - 2023, Value ($ Billion)
  • 5.3. Global Autoimmune Disease Diagnosis Forecast Market Size and Growth, 2023 - 2028, 2033F, Value ($ Billion)

6. Autoimmune Disease Diagnosis Market Segmentation

  • 6.1. Global Autoimmune Disease Diagnosis Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Consumables & Assay Kits
  • Instruments
  • 6.2. Global Autoimmune Disease Diagnosis Market, Segmentation By Test Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Routine Laboratory Tests
  • Autoantibodies Tests
  • Immunologic Tests
  • Other Tests
  • 6.3. Global Autoimmune Disease Diagnosis Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Clinical Laboratories
  • Hospitals
  • Other End Users

7. Autoimmune Disease Diagnosis Market Regional And Country Analysis

  • 7.1. Global Autoimmune Disease Diagnosis Market, Split By Region, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 7.2. Global Autoimmune Disease Diagnosis Market, Split By Country, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

8. Asia-Pacific Autoimmune Disease Diagnosis Market

  • 8.1. Asia-Pacific Autoimmune Disease Diagnosis Market Overview
  • Region Information, Impact Of COVID-19, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 8.2. Asia-Pacific Autoimmune Disease Diagnosis Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 8.3. Asia-Pacific Autoimmune Disease Diagnosis Market, Segmentation By Test Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 8.4. Asia-Pacific Autoimmune Disease Diagnosis Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

9. China Autoimmune Disease Diagnosis Market

  • 9.1. China Autoimmune Disease Diagnosis Market Overview
  • 9.2. China Autoimmune Disease Diagnosis Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion
  • 9.3. China Autoimmune Disease Diagnosis Market, Segmentation By Test Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion
  • 9.4. China Autoimmune Disease Diagnosis Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion

10. India Autoimmune Disease Diagnosis Market

  • 10.1. India Autoimmune Disease Diagnosis Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 10.2. India Autoimmune Disease Diagnosis Market, Segmentation By Test Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 10.3. India Autoimmune Disease Diagnosis Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

11. Japan Autoimmune Disease Diagnosis Market

  • 11.1. Japan Autoimmune Disease Diagnosis Market Overview
  • 11.2. Japan Autoimmune Disease Diagnosis Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 11.3. Japan Autoimmune Disease Diagnosis Market, Segmentation By Test Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 11.4. Japan Autoimmune Disease Diagnosis Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

12. Australia Autoimmune Disease Diagnosis Market

  • 12.1. Australia Autoimmune Disease Diagnosis Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 12.2. Australia Autoimmune Disease Diagnosis Market, Segmentation By Test Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 12.3. Australia Autoimmune Disease Diagnosis Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

13. Indonesia Autoimmune Disease Diagnosis Market

  • 13.1. Indonesia Autoimmune Disease Diagnosis Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 13.2. Indonesia Autoimmune Disease Diagnosis Market, Segmentation By Test Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 13.3. Indonesia Autoimmune Disease Diagnosis Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

14. South Korea Autoimmune Disease Diagnosis Market

  • 14.1. South Korea Autoimmune Disease Diagnosis Market Overview
  • 14.2. South Korea Autoimmune Disease Diagnosis Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 14.3. South Korea Autoimmune Disease Diagnosis Market, Segmentation By Test Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 14.4. South Korea Autoimmune Disease Diagnosis Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

15. Western Europe Autoimmune Disease Diagnosis Market

  • 15.1. Western Europe Autoimmune Disease Diagnosis Market Overview
  • 15.2. Western Europe Autoimmune Disease Diagnosis Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 15.3. Western Europe Autoimmune Disease Diagnosis Market, Segmentation By Test Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 15.4. Western Europe Autoimmune Disease Diagnosis Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

16. UK Autoimmune Disease Diagnosis Market

  • 16.1. UK Autoimmune Disease Diagnosis Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 16.2. UK Autoimmune Disease Diagnosis Market, Segmentation By Test Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 16.3. UK Autoimmune Disease Diagnosis Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

17. Germany Autoimmune Disease Diagnosis Market

  • 17.1. Germany Autoimmune Disease Diagnosis Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 17.2. Germany Autoimmune Disease Diagnosis Market, Segmentation By Test Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 17.3. Germany Autoimmune Disease Diagnosis Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

18. France Autoimmune Disease Diagnosis Market

  • 18.1. France Autoimmune Disease Diagnosis Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 18.2. France Autoimmune Disease Diagnosis Market, Segmentation By Test Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 18.3. France Autoimmune Disease Diagnosis Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

19. Italy Autoimmune Disease Diagnosis Market

  • 19.1. Italy Autoimmune Disease Diagnosis Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 19.2. Italy Autoimmune Disease Diagnosis Market, Segmentation By Test Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 19.3. Italy Autoimmune Disease Diagnosis Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

20. Spain Autoimmune Disease Diagnosis Market

  • 20.1. Spain Autoimmune Disease Diagnosis Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 20.2. Spain Autoimmune Disease Diagnosis Market, Segmentation By Test Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 20.3. Spain Autoimmune Disease Diagnosis Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

21. Eastern Europe Autoimmune Disease Diagnosis Market

  • 21.1. Eastern Europe Autoimmune Disease Diagnosis Market Overview
  • 21.2. Eastern Europe Autoimmune Disease Diagnosis Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 21.3. Eastern Europe Autoimmune Disease Diagnosis Market, Segmentation By Test Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 21.4. Eastern Europe Autoimmune Disease Diagnosis Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

22. Russia Autoimmune Disease Diagnosis Market

  • 22.1. Russia Autoimmune Disease Diagnosis Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 22.2. Russia Autoimmune Disease Diagnosis Market, Segmentation By Test Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 22.3. Russia Autoimmune Disease Diagnosis Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

23. North America Autoimmune Disease Diagnosis Market

  • 23.1. North America Autoimmune Disease Diagnosis Market Overview
  • 23.2. North America Autoimmune Disease Diagnosis Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 23.3. North America Autoimmune Disease Diagnosis Market, Segmentation By Test Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 23.4. North America Autoimmune Disease Diagnosis Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

24. USA Autoimmune Disease Diagnosis Market

  • 24.1. USA Autoimmune Disease Diagnosis Market Overview
  • 24.2. USA Autoimmune Disease Diagnosis Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 24.3. USA Autoimmune Disease Diagnosis Market, Segmentation By Test Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 24.4. USA Autoimmune Disease Diagnosis Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

25. Canada Autoimmune Disease Diagnosis Market

  • 25.1. Canada Autoimmune Disease Diagnosis Market Overview
  • 25.2. Canada Autoimmune Disease Diagnosis Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 25.3. Canada Autoimmune Disease Diagnosis Market, Segmentation By Test Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 25.4. Canada Autoimmune Disease Diagnosis Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

26. South America Autoimmune Disease Diagnosis Market

  • 26.1. South America Autoimmune Disease Diagnosis Market Overview
  • 26.2. South America Autoimmune Disease Diagnosis Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 26.3. South America Autoimmune Disease Diagnosis Market, Segmentation By Test Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 26.4. South America Autoimmune Disease Diagnosis Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

27. Brazil Autoimmune Disease Diagnosis Market

  • 27.1. Brazil Autoimmune Disease Diagnosis Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 27.2. Brazil Autoimmune Disease Diagnosis Market, Segmentation By Test Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 27.3. Brazil Autoimmune Disease Diagnosis Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

28. Middle East Autoimmune Disease Diagnosis Market

  • 28.1. Middle East Autoimmune Disease Diagnosis Market Overview
  • 28.2. Middle East Autoimmune Disease Diagnosis Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 28.3. Middle East Autoimmune Disease Diagnosis Market, Segmentation By Test Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 28.4. Middle East Autoimmune Disease Diagnosis Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

29. Africa Autoimmune Disease Diagnosis Market

  • 29.1. Africa Autoimmune Disease Diagnosis Market Overview
  • 29.2. Africa Autoimmune Disease Diagnosis Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 29.3. Africa Autoimmune Disease Diagnosis Market, Segmentation By Test Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 29.4. Africa Autoimmune Disease Diagnosis Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

30. Autoimmune Disease Diagnosis Market Competitive Landscape And Company Profiles

  • 30.1. Autoimmune Disease Diagnosis Market Competitive Landscape
  • 30.2. Autoimmune Disease Diagnosis Market Company Profiles
    • 30.2.1. Siemens Healthineers AG
      • 30.2.1.1. Overview
      • 30.2.1.2. Products and Services
      • 30.2.1.3. Strategy
      • 30.2.1.4. Financial Performance
    • 30.2.2. Abbott Laboratories
      • 30.2.2.1. Overview
      • 30.2.2.2. Products and Services
      • 30.2.2.3. Strategy
      • 30.2.2.4. Financial Performance
    • 30.2.3. Thermo Fisher Scientific Inc
      • 30.2.3.1. Overview
      • 30.2.3.2. Products and Services
      • 30.2.3.3. Strategy
      • 30.2.3.4. Financial Performance
    • 30.2.4. Bio-Rad Laboratories Inc
      • 30.2.4.1. Overview
      • 30.2.4.2. Products and Services
      • 30.2.4.3. Strategy
      • 30.2.4.4. Financial Performance
    • 30.2.5. F. Hoffmann-La Roche Ltd
      • 30.2.5.1. Overview
      • 30.2.5.2. Products and Services
      • 30.2.5.3. Strategy
      • 30.2.5.4. Financial Performance

31. Autoimmune Disease Diagnosis Market Other Major And Innovative Companies

  • 31.1. Danaher Corporation
  • 31.2. AESKU Diagnostics GmbH & Co. KG
  • 31.3. Trinity Biotech plc.
  • 31.4. bioMerieux SA
  • 31.5. SQI Diagnostics
  • 31.6. SCHILLER Healthcare India Pvt. Ltd
  • 31.7. Covidien Healthcare India Private Limited
  • 31.8. Philips Healthcare India
  • 31.9. Fisher & Paykel Healthcare India Private Limited
  • 31.10. Smith's Medical India Pvt Ltd
  • 31.11. Agappe Diagnostics Ltd
  • 31.12. Accord Medical Products Private Limited
  • 31.13. Terumo Corporation
  • 31.14. Olympus Medical Systems Corporation
  • 31.15. Canon Medical Systems Corporation

32. Global Autoimmune Disease Diagnosis Market Competitive Benchmarking

33. Global Autoimmune Disease Diagnosis Market Competitive Dashboard

34. Key Mergers And Acquisitions In The Autoimmune Disease Diagnosis Market

35. Autoimmune Disease Diagnosis Market Future Outlook and Potential Analysis

  • 35.1 Autoimmune Disease Diagnosis Market In 2028 - Countries Offering Most New Opportunities
  • 35.2 Autoimmune Disease Diagnosis Market In 2028 - Segments Offering Most New Opportunities
  • 35.3 Autoimmune Disease Diagnosis Market In 2028 - Growth Strategies
    • 35.3.1 Market Trend Based Strategies
    • 35.3.2 Competitor Strategies

36. Appendix

  • 36.1. Abbreviations
  • 36.2. Currencies
  • 36.3. Historic And Forecast Inflation Rates
  • 36.4. Research Inquiries
  • 36.5. The Business Research Company
  • 36.6. Copyright And Disclaimer